Celebrating scientific impact and collaboration, our innovations and launches, and special features and resources
View in browser
Visiopharm logo
The Intel - Your monthly newsletter from Visiopharm

As we step into 2025, we at Visiopharm want to take a moment to reflect on the remarkable milestones we achieved in 2024, all thanks to your support. This January's edition of The Intel is dedicated to celebrating these accomplishments and setting our sights on future innovations.

2024 highlights in numbers

Celebrating scientific impact

We're thrilled to share that over 550 scientific publications mentioned Visiopharm's software in 2024. This significant milestone underscores our commitment to advancing scientific discovery and our contribution to the broader scientific community. Explore our handpicked selection of impactful research here.

 

Connecting in person

2024 was a year of active engagement for us. We hit the road, attended various industry events, and engaged directly with our valued customers and partners, with whom we collaborated on over 20 posters. Discover findings shared at major conferences here.

other-email-the-intel-0824_UMCU_AI_team

Photo taken by Ivar Pel

Visiopharm and UMC Utrecht achieve breakthrough in AI-powered detection of breast cancer lymph node metastases


Visiopharm’s AI APP was featured in Nature Cancer, thanks to UMC Utrecht's groundbreaking study on AI-powered detection of breast cancer lymph node metastases. 

Read more about the breakthrough
Innovations and launches

Launch of new HER2 APP 

Fully automatic single-cell approach for HER2 IHC quantification that follows ASCO/CAP guidelines.

Video: HER2 low APP sneak peak
Learn more about the APP

Check out our HER2 ultralow study presented at SABC 2024: Download poster 

Launch of new PACS/IMS integrations

PACS_IMS integrations

Seemless integration is key when using AI in the fully digital pathology lab. Visiopharm’s hassle-free integration in your PACS/IMS (e.g Sectra IDS7) allows a fully automated workflow from scanning to reviewing.

Read more about the integrations

Advanced spatial neighborhood capabilities   

Phenoplex v3: Advanced spatial neighborhood capabilities

The latest version of Phenoplex introduced groundbreaking features for spatial neighborhood analysis, allowing users to define custom radii and quantify and visualize specific cellular neighbors. 

Read more about the capabilities 
Partnerships
Automated ROI/AOI analysis for GeoMx DSP users

Automated ROI/AOI analysis for GeoMx DSP users

With our partnership with Bruker Spatial Biology (formerly Nanostring), GeoMx users can leverage Oncotopix® Discovery AI-driven software to enhance tissue segmentation, speed up the ROI selection process, and standardize GeoMx results.

Learn more: partnership with Bruker Spatial Biology
Grundium scanner and Qualitopix

Qualitopix: Trust your staining through AI driven quantification and monitoring 

In 2024, Qualitopix partnered with Grundium to help you standardize your tissue biomarker staining with a complete workflow from scanning to documentation. 

Learn more: partnership with Grundium
Special features and resources
Masterclass Series: Spatial Biology - image analysis and practical application

Successful Spatial Biology series

We successfully concluded our 2024 Spatial Biology Masterclass Series, featuring seven expert-led sessions by renowned speakers such as Prof. Jared Burks, Dr. Janusz Franco-Barraza, OracleBio, and others. These masterclasses delved into advanced image analysis techniques and showcased the innovative applications of Phenoplex in spatial biology research. 

Watch the recordings
Click me
Click me
Click me
Click me
linkedIn-icon

Visiopharm, Agern Allé 24, Hørsholm, - 2970, Denmark

Unsubscribe Manage preferences

Forward to a Friend